Odyssey Group International Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
6
- Stock Symbol
-
ODYY
- Investments
-
4
- Share Price
-
$0.13
- (As of Friday Closing)
Odyssey Group International General Information
Description
Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity.
Contact Information
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Capital Markets/Institutions
Stock Exchange
PINX
Primary Office
- 2372 Morse Avenue
- Irvine, CA 92614
- United States
+1 (702) 000-0000
Odyssey Group International Timeline
Odyssey Group International Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.13 | $0.16 | $0.06 - $0.39 | $10.6M | 81.7M | 144K | -$0.07 |
Odyssey Group International Financials Summary
|
In Thousands, USD |
TTM 31-Jul-2023 | FY 2023 31-Jul-2023 | FY 2022 31-Jul-2022 | FY 2021 31-Jul-2021 |
|---|---|---|---|---|
| EV | 12,885 | 12,885 | 17,286 | 48,916 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (5,302) | (5,302) | (7,605) | (15,805) |
| Net Income | (5,919) | (5,919) | (8,444) | (16,883) |
| Total Assets | 456 | 456 | 570 | 611 |
| Total Debt | 2,145 | 2,145 | 1,532 | 736 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Odyssey Group International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Odyssey Group International Patents
Odyssey Group International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-8454624-B2 | Device for removing a lodged mass | Active | 25-Feb-2011 | 000000000 | 00 |
| US-20120221010-A1 | Device for removing a lodged mass | Active | 25-Feb-2011 | 000000000 | 00 |
| US-20060161170-A1 | Device for removing a lodged mass | Active | 19-Jan-2005 | 00000000 | |
| US-7559921-B2 | Device for removing a lodged mass | Inactive | 19-Jan-2005 | 00000000 | |
| US-RE45535-E1 | Device for removing a lodged mass | Active | 19-Jan-2005 | A61D1/12 |
Odyssey Group International Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Joseph Redmond | President, Chief Executive Officer & Board Member | ||
| Christine Farrell | Chief Financial Officer & Secretary |
Odyssey Group International Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Odyssey Group International Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Odyssey Group International Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Speranza Therapeutics | 23-Jun-2023 | 0000000000 | Therapeutic Devices | ||
| Prevacus (Concussion Drug in Tallahassee, Florida) | 02-Mar-2021 | 000000000 | Buildings and Property | ||
| Joint Venture (Prevacus / Odyssey) | 27-Jun-2019 | 00000 0000 | Biotechnology | ||
| Well-Med Global | 13-Jan-2014 | Merger of Equals | Pharmaceuticals |
Odyssey Group International Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Odyssey Health (proprietary neurological drug therapies and technologies) | Other Healthcare Technology Systems | Las Vegas, NV |